BioDuro – Sundia’s pharmacology team has extensive drug discovery and development experience in the pharmaceutical industry enabling us to support fully integrated programs, including study design and data interpretation. Special expertise in metabolic and inﬂammatory diseases is coupled with a commitment to working with clients to develop customized models to address specific needs of drug discovery programs.
Immunology & Inflammation (I & I)
Inflammation and Immunology Disease Models
Respiratory Disease Models
Metabolic Diseases Animal Models
In Vivo Assays
Cardiovascular & Metabolic Diseases (CVMD)
BioDuro-Sundia’s pharmacology team has developed highly clinically translatable animal NASH models to evaluate drug candidates. With short NASH induction periods of 12 – 16 weeks in mice and 8 – 12 weeks in hamsters our NASH models successfully mimic the pathogenesis of clinical NASH patients and exhibit hallmarks of NASH, including steatosis, lobular inflammation, ballooning and fibrosis.